Company:  HOSPIRA INC (HSP)
Form Type:  10-K
Filing Date:  2/13/2013 
CIK:  0001274057 
Address:  275 FIELD DR 
City, State, Zip:  LAKE FOREST, Illinois 60045 
Telephone:  (847) 937-6472 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$43.96  
Change: 
0.20 (0.46%)  
Trade Time: 
Apr 24  
Market Cap: 
$7.34B
Description of Business
Hospira, Inc. ("Hospira") is a provider of injectable pharmaceutical drugs and infusion technologies that it develops, manufactures, distributes and markets globally. Through a broad, integrated product portfolio, Hospira is uniquely positioned to Advance Wellness� by improving patient and caregiver safety while reducing healthcare costs. Hospira's portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. Hospira's broad portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. Hospira was incorporated in Delaware on September 16, 2003, as a wholly owned subsidiary of Abbott Laboratories ("Abbott"). Hospira's business first began operation as part of Abbott in the 1930s.
Register for EDGAR Pro and access this filing in:     
  FORM 10-K
    PART I
      Item 1. Business
      Item 1A. Risk Factors
      Item 1B. Unresolved Staff Comments
      Item 2. Properties
      Item 3. Legal Proceedings
    PART II
      Item 5. Market for Registrant's Common Equity, Related ...
      Item 6. Selected Financial Data
      Item 7. Management's Discussion and Analysis of Financial ...
        Liquidity and Capital Resources
          BALANCE SHEET
      Item 7A. Quantitative and Qualitative Disclosures About ...
      Item 8. Financial Statements and Supplementary Data
        REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
        REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
        INCOME STATEMENT
        CASH FLOW
        BALANCE SHEET
        STOCKHOLDERS EQUITY
        Notes to Consolidated Financial Statements
          INCOME STATEMENT
          INCOME STATEMENT
      Item 9. Changes in and Disagreements With Accountants on ...
      Item 9A. Controls and Procedures
      Item 9B. Other Information
    PART III
      Item 10. Directors, Executive Officers and Corporate Governance
      Item 11. Executive Compensation
      Item 12. Security Ownership of Certain Beneficial Owners ...
      Item 13. Certain Relationships and Related Transactions, and ...
      Item 14. Principal Accountant Fees and Services
    PART IV
      Item 15. Exhibits and Financial Statement Schedules
    SIGNATURES
    VALUATION AND QUALIFYING ACCOUNTS
    EXHIBIT INDEX
  EXHIBIT 2.3
  EXHIBIT 2.4
  EXHIBIT 10.5
  EXHIBIT 10.6(C)
  EXHIBIT 12.1
    RATIO COMPUTATION
  EXHIBIT 18
  EXHIBIT 21.1
    SUBSIDIARIES
  EXHIBIT 23.1
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
  EXHIBIT 31.1
    Certification of Chief Executive Officer
  EXHIBIT 31.2
  EXHIBIT 32.1
    Certification of Chief Executive Officer Pursuant To
  EXHIBIT 32.2
    Certification of Chief Financial Officer Pursuant To
BROKERAGE PARTNERS